Is Indivior Pharmaceuticals Inc overvalued?

Indivior Pharmaceuticals Inc (INDV) looks undervalued — trading about 41% below its fair value.

Undervalued

Price

$35.82

Fair value

$50.59

Current P/E

11.9

Normal P/E

16.8

Market cap

$4.47B

Dividend yield

0.0%

Return on equity

-216.1%

Sector

Healthcare

Fair value compares INDV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks